Due to the critical role of circRNAs in regulating the PD-1/PD-L1 pathway, these circRNAs are considered as adjuvant immunotherapy targets to improve the efficiency of immune checkpoint inhibition therapy in cancer patients. Here, CD274 is linked to cancer.